609TiPPRODIGE 50 - ASPIK French: French double blind randomised study of aspirin versus placebo in resected stage III or high risk stage II colon cancer with PIK3CA mutation - Université de Bourgogne Accéder directement au contenu
Communication Dans Un Congrès Année : 2017

609TiPPRODIGE 50 - ASPIK French: French double blind randomised study of aspirin versus placebo in resected stage III or high risk stage II colon cancer with PIK3CA mutation

Mots clés

Domaines

Cancer

Dates et versions

hal-01632463 , version 1 (10-11-2017)

Identifiants

Citer

P. Michel, T. André, V. Boige, T. Aparicio, E. Maillard, et al.. 609TiPPRODIGE 50 - ASPIK French: French double blind randomised study of aspirin versus placebo in resected stage III or high risk stage II colon cancer with PIK3CA mutation. the 42nd ESMO Congress (ESMO 2017), Sep 2017, Madrid, Spain. ⟨10.1093/annonc/mdx393.134⟩. ⟨hal-01632463⟩
125 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More